Navigation Links
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
Date:4/29/2013

lease contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, we are using forward-looking statements when we discuss how the results of our study demonstrate that our technology effectively delivers insulin without compromising its bioactivity, and serve as an impetus to realize the therapeutic potential of ORMD-0801 in regulating T1DM, or when we discuss our oral insulin and oral exenatide candidates approaching Phase 2 clinical trials under U.S. IND and 2a clinical trials, respectively. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval

or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
2. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
3. Oramed Submits New IND Application for Oral Insulin Trial in the US
4. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
5. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
8. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
9. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
10. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
11. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... 16, 2015 Mindray Medical International Limited (NYSE: ... marketer of medical devices worldwide, announced today that ... Commission an Annual Report on Form 20-F that included ... 2014. An electronic version of Mindray,s Annual Report ... relations website at  http://ir.mindray.com  or  http://www.sec.gov . ...
(Date:4/16/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... on Tuesday, April 21, 2015, after the close of ... by a conference call with the investment community at ... will be Robert A. Bradway , chairman and ... management team. Live audio of the conference ...
(Date:4/16/2015)...  Rosewind Corporation (OTCMKTS: RSWN) announced today that ... newly formed specialty healthcare company focused on redox-modulated ... disorders. The merged company, which is expected to ... and incorporates the pipeline assets of both Vyrix ... to build a late-stage and commercial pipeline of ...
Breaking Medicine Technology:Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Menicon Co., Ltd. (Menicon) announced the appointment of Chew Hwee ... office in Nagoya, Japan. Chew, to be based in Nagoya, ... as well as external relations to support the company,s globalization. ... Economic Development Board (EDB). During his nine-year tenure with the ...
... Aug. 31 Zimmer Holdings, Inc. (NYSE: ZMH ... that it will be participating in the Morgan Stanley Global ... 13, 2010 at 8:35 a.m. Eastern Time. A ... Investor Relations website at http://investor.zimmer.com .  The webcast will ...
Cached Medicine Technology:Former Singapore EDB Officer, Chew Hwee Yong, Joins Menicon as Chief of Special Projects as Menicon Accelerates its Globalization 2Zimmer Holdings to Present at Morgan Stanley Global Healthcare Unplugged Conference 2Zimmer Holdings to Present at Morgan Stanley Global Healthcare Unplugged Conference 3
(Date:4/17/2015)... Texas (PRWEB) April 17, 2015 From the ... years ago, the Texas non-profit organization has empowered young people ... its effort to bring fresh water and the Gospel ... with Liberty University. Between March 17 and 27, students, faculty ... provide 7,000 Liberians with fresh water and the Good News ...
(Date:4/17/2015)... Rapids, MI (PRWEB) April 17, 2015 Enthusiasts ... CRUSH Grand Rapids, Saturday, April 25, 2015. The event will ... Reserve Wine & Food (201 Monroe Ave NW, Grand Rapids, ... from around the West Michigan area. Patrons are encouraged to ... of elegance and fun. , This year’s event will feature ...
(Date:4/17/2015)... 2015 Testosterone treatment lawsuits ( ... prescription medications increases the likelihood that a man ... life-threatening cardiovascular event continue to mount in a ... District of Illinois. According to an updated Statistics ... Multidistrict Litigation (JPML) on April 15th, 1,382 cases ...
(Date:4/17/2015)... Francisco, CA (PRWEB) April 17, 2015 The American ... House event and Free Application Day on April 29. The event ... ACTCM Pioneer Square, located at 555 DeHaro St. in San Francisco, ... 11 a.m. – Check in at the DeHaro campus (room F), ... – Tour of campus, Noon – Light lunch with current students, ...
(Date:4/17/2015)... 17, 2015 With Dr. Taj Haynes ... has spent the last four years providing residents of ... ranging from general cleanings to dental implants and Invisalign ... at their new office in North Charlotte. , The ... their Concord office, including denture fittings, cosmetic procedures, and ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... if there is no sound (silence). The brain is activated ... ,Pierre Fonlupt and Julien Voisin conducted the research ... activity of 11patients who were at rest with the help ... were actually listening to silence and also listen for the ...
... pain and very pale skin can all be early warning ... ,Thousand’s of children's lives will be saved the ... parents, which could speed diagnosis and treatment. ,Until ... child having a headache, stiff neck, sensitivity to light and ...
... team from McMaster University in their clinical trial reported ... drugs such as amiodarone combined with beta blockers such ... in ventricular arrhythmia patients undergoing Implantable Cardioverter defibrillator (ICD). ... to treat fatal cases of ventricular arrhythmias, but these ...
... a time when there is lot of relaxation in weight reduction ... to get this going is to listen to one’s inner voice ... ,Usually the little inner voice starts piping up as you lie ... "Take a handful of those potato chips," it urges., ...
... of H5N1 bird flu strain in Turkey had led to ... summer to avoid spread of bird flu virus into Britain. ... tourists are booking holidays in Turkish resorts.// The Association of ... Turkey is as usual and people seem to be not ...
... study conducted in Japan it has been shown that tomato ... is a known cause of the lung-destroying disease. // ... in tomatoes. ,This study appears to be the ... ,As a cautionary word by the researchers, 'We can't simply ...
Cached Medicine News:Health News:New warning signs for child meningitis 2Health News:Being Active In Winter Despite That Inner Urge 2
... Portex® Blue Line® uncuffed endotracheal ... or Murphy styles, in standard ... Line® adult and pediatric uncuffed ... implant-tested polyvinyl chloride with a ...
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
Ruschelit® PVC. Murphy eye-nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Medicine Products: